Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease

Yeon-Jeong Kim; Sun-Young Chang; Hyun-Jeong Ko

doi:10.5217/ir.2015.13.2.105

Articles

Page Path: HOME > Intest Res > Volume 13(2); 2015 > Article

Review Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease: Yeon-Jeong Kim¹, Sun-Young Chang², Hyun-Jeong Ko³; Intestinal Research 2015;13(2):105-111.
DOI: https://doi.org/10.5217/ir.2015.13.2.105
Published online: April 27, 2015

¹College of Pharmacy, Inje University, Gimhae, Korea.

²College of Pharmacy, Ajou University, Suwon, Korea.

³College of Pharmacy, Kangwon National University, Chuncheon, Korea.

Correspondence to Hyun-Jeong Ko, Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, 1 Gangwondaehak-gil, Chuncheon 200-701, Korea. Tel: +82-33-250-6923, Fax: +82-33-255-7865, hjko@kangwon.ac.kr

• Received: January 16, 2015 • Revised: January 20, 2015 • Accepted: January 21, 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next

5,981 Views
92 Download
21 Web of Science
21 Crossref

Full Article

Download PDF

Abstract
INTRODUCTION
MDSCs IN IMMUNE SYSTEMS
MDSCs IN IBD
ER STRESS AND IBD
ER STRESS AND THE DIVERGENT FUNCTIONS OF MDSCs
CONCLUSIONS
NOTES
REFERENCES

Abstract

Immature myeloid cells, also known as myeloid-derived suppressor cells (MDSCs), include neutrophilic and monocytic myeloid cells, and are found in inflammatory loci and secondary lymphoid organs in mice with intestinal inflammation, inflammatory bowel disease (IBD) patients, and tumor tissues. However, the roles of MDSCs in IBD are not yet well understood, and there are controversies regarding their immunosuppressive functions in IBD. In addition, recent studies have suggested that endoplasmic reticulum (ER) stress in intestinal epithelial cells, especially in Paneth cells, is closely associated with the induction of IBD. However, the ER stress in MDSCs accumulated in the inflamed tissues of IBD patients is not yet fully understood. In the current review, we discuss the presence of accumulated MDSCs in the intestines of IBD patients, and further speculate on their physiological roles in the inflammatory condition with interleukin 17-producing cells, including Th17 cells. In particular, we will discuss the divergent functions of MDSCs in ER stressed intestinal environments, including their pro-inflammatory or immunosuppressive roles, based on the consideration of unfolded protein responses initiated in intestinal epithelial cells by ER stress.
Keywords: Inflammatory bowel diseases; Myeloid-derived suppressor cell; Endoplasmic reticulum stress; Intestines; Interleukin-17

INTRODUCTION

Inflammatory bowel disease (IBD) is a chronic inflammatory condition in the small and large bowel, and includes two major clinical forms, Crohn's disease (CD) and ulcerative colitis (UC).1 Although the exact causes of IBD are largely unknown, early studies aimed at identifying the genetic factors associated with human IBD revealed nucleotide-binding oligomerization domain-containing protein 2 (NOD2) as a CD-susceptibility gene.2 Ever since NOD2 was introduced, many researchers have tried to find other genetic risk factors for IBD. Based on the efforts of many researchers, a considerable number of genetic risk factors, including solute carrier family 22, member 4 (SLC22A4), SLC22A5, prostaglandin E receptor 4 (PTGER4), interleukin 23 receptor (IL23R), autophagy related 16-like 1 (ATG16L1), immunity-related GTPase family M (IRGM), discs, large homolog 5 (DLG5), and X-box binding protein 1 (XBP1) have been found to be associated with the development of IBD in addition to NOD2.3,4,5 Among them, the genetic association of XBP1 polymorphisms with IBD was suggested by the presence of hypomorphic single-nucleotide polymorphisms in the XBP1 gene in IBD patients, and unabated endoplasmic reticulum (ER) stress was associated with the induction of intestinal inflammation shown in IBD patients.4

Interestingly, several genetic risk factors of IBD were found to be involved in the maturation and function of Paneth cells.6,7 Paneth cells are specialized epithelial cells that reside in the crypts of the small intestine, and produce antimicrobial materials including defensins and lysozymes.8 Reduced antimicrobial function of defensins was reported in IBD patients with a genetic risk factor allele of the NOD2 gene,9 and transcription factor 4 (TCF4), a Wnt transcription factor, is also known to be critical for the proper functioning of Paneth cells and was suggested as another genetic risk factor associated with IBD.10 In addition, XBP1 and ATG16L1 converge in Paneth cells as primary factors of IBD, and ER stress exacerbated by XBP1 deficiency might be attenuated by the compensatory mechanism of autophagy activation in Paneth cells.6

In the inflammatory loci of IBD patients, there is massive infiltration of inflammatory cells including T cells, neutrophils, monocytes, and macrophages.11,12 Recently, the presence of immature myeloid cells, also known as myeloid-derived suppressor cells (MDSCs), was also detected in IBD patients as well as in animal models of IBD.13 In this review, we will discuss the accumulation and functions of MDSCs in IBD-associated intestinal inflammatory conditions, and a possible association of ER stress on the inflammatory or suppressive functions of MDSC's.

MDSCs IN IMMUNE SYSTEMS

MDSCs are a heterogeneous cell population consisting of macrophage precursors, dendritic cells, granulocytes, and early myeloid progenitors.14 The definition of this cell population is based on its origin, myeloid lineage, and its immunosuppressive function. Since the term "MDSC" does not directly reflect the immaturity of this population, they are also called immature myeloid cells.15 They expand during pathological conditions, including infections, inflammations, and cancers in experimental animal models, as well as in human patients.14,16 There are two main subsets of MDSCs: polymorphonuclear MDSCs (PMN-MDSCs) and monocytic MDSCs (Mo-MDSCs), especially in murine models of tumor transplantation.17,18 In mice, PMN-MDSCs are CD11b⁺Ly-6G⁺Ly-6C^low cells, while Mo-MDSCs are CD11b⁺Ly-6G^-Ly-6C^high cells.19 There are some differences in suppressive capacity and functional mechanism between the two subsets20 and both PMN-MDSCs and Mo-MDSCs can be found in humans.16,21

In the immune system, it is known that the major role of MDSCs is immune suppression, and this seems to be especially true in tumor tissues.15,16 The accumulation of MDSCs in tumor-bearing mice and cancer patients is correlated with poor prognoses. MDSCs can inhibit the proliferation and cytokine production of CD4⁺ and CD8⁺ T cells through amino acid deprivation and the release of oxidizing molecules.22 They also induce regulatory T cells to suppress immune responses against tumor cells.23 Besides, they can modulate the function of T cells as well as their migration and viability.22 In addition to T cell inhibition, MDSCs suppressed natural killer (NK) cell cytotoxicity and cytokine production,24 and suppress the antigen presenting functions of dendritic cells.25

Despite their inherent suppressive functions, MDSCs can be converted into immunostimulatory myeloid cells in specific circumstances.26 In acute inflammation, such as trauma and sepsis, MDSCs are the sentinel cells for immune-surveillance and act as immune effectors.27 Even in the ovarian cancer model, MDSCs in ascites play a role as immunostimulatory antigen presenting cells (APCs).28 Furthermore, there is plasticity in the suppressive function of MDSCs. Our recent study also showed that intra-tumoral injection of attenuated Salmonella induced tumor necrosis factor α (TNF-α)-producing PMN-MDSCs, which can function as immune effectors.19 With the help of NKT cells, MDSCs became immunogenic APCs and stimulated antigen specific T cells.29,30 Hence, the divergent roles and the functional plasticity of MDSCs are now interesting subjects in MDSC studies.

MDSCs IN IBD

IBD is an autoimmune-associated disease characterized by small and large intestinal inflammation.31 There are two major forms of IBD, CD and UC.1 In the chronic inflammatory condition of IBD, there are complex interactions between several immune cells infiltrating into the intestinal mucosa, with epithelial cells even ignoring the effects of microbiota.11 Among them, myeloid cells, including neutrophils, macrophages, and MDSCs, have been a focus of study due to their divergent role in inflammation.32 In particular, the immunosuppressive function of MDSCs was suggested in several mouse models of IBD (Table 1). It was reported that CD11b⁺Gr-1⁺ MDSCs were accumulated in a murine colitis model, and they expressed nitric oxide synthase 2 and arginase, which are known to be critical functional mediators of MDSCs.32 As well as in a model of IBD, CD14⁺HLA-DR^low MDSCs with suppressive functions were reported to be increased in the peripheral blood of IBD patients.32

Besides MDSCs in IBD models being initially reported as immunosuppressive, as shown in tumor-bearing hosts, the roles of MDSCs during intestinal inflammation have become controversial since recent studies suggested that they functioned as pro-inflammatory myeloid cells. Colonic Mac-1⁺Ly6C^intGr-1⁺ cells, similar to PMN-MDSCs, acquired stimulatory APC functions and induced T cell activation and pro-inflammatory cytokine production.33 In addition, adoptive transferred Ly6C^hi monocytes were converted into pro-inflammatory cells. They then contributed to intestinal inflammation,12 and produced pro-inflammatory cytokines in a murine model of IBD.34

These controversial roles of MDSCs in IBD might be partially due to interleukin 17 (IL-17) cytokine production, which could be at least partially ascribed to increased differentiation of Th17 cells. Th17 cells are known to act as pathogenic effector cells in various immune-related diseases, including experimental autoimmune encephalomyelitis, arthritis, and IBD.13 In the case of IL-17, one study showed that this cytokine had a pathogenic role in severe intestinal inflammation, 35 but another study demonstrated IL-17-mediated protection in murine colitis.36

Interestingly, it was recently reported that CD11b⁺Gr-1⁺ MDSCs enhanced Th17 cell differentiation and contributed to the pathogenesis of experimental autoimmune encephalomyelitis. 37 Likewise, a recent study showed that immunosuppressive MDSCs inhibited Th1 responses while they enhanced Th17 generation.38 In a chronic colitis model, pro-inflammatory colonic Mac-1⁺Ly6C^intGr-1⁺ cells induced IL-17 production by T cells.33 Collectively, this series of studies suggest that MDSCs induced by intestinal inflammation conditions might be involved in Th17 generation and IL-17 production. As described, Th17 cells can contribute to establishing the pro-inflammatory environment and pathogenesis of IBD. On the contrary, MDSCs were initially reported to inhibit the production of several pro-inflammatory cytokines including IL-17, and functioned as immune regulators in several other inflammatory conditions including cancer and chronic infections.39 Thus, the role of MDSCs in IBD is still controversial, and might be closely associated with the production of IL-17 or the induction of IL-17-producing T cells.

ER STRESS AND IBD

ER is a type of organelle in eukaryotic cells responsible for the folding, modification, maturation, and trafficking of newly synthesized proteins, and only properly folded proteins are transported from the rough ER to the Golgi apparatus for secretion.40 Thus, the precise regulation of ER function is critical for the maintenance of cellular homeostasis.41 The condition in which unfolded or misfolded proteins accumulated in the ER is known as ER stress, and can be caused by several factors including disturbances in redox regulation, calcium regulation, glucose deprivation, and viral infection.42 Experimentally, several conditions including ER Ca²⁺ depletion, defective glycosylation, viral infection, and inflammatory conditions are also known to induce ER stress.43

ER stress activates multiple cellular processes known as unfolded protein responses (UPRs), and three branches of UPRs have been discussed extensively in previous reviews. 42,44 Under ER stress conditions, misfolded or unfolded protein are accumulated in the ER lumen, and trigger UPRs to restore normal ER function. UPR signaling results in the adaptation of cells to ER stress by increasing activation of ER chaperon function, ER trafficking, degradation of ER-resident protein, as well as by inhibiting CAP-dependent translation through phosphorylation of the α-subunit of eukaryotic initiation factor 2 (eIF2α).45 Otherwise, excessive ER stress induces apoptosis via C/EBP-homologous protein (CHOP) and the inositol-requiring transmembrane kinase/endonuclease 1α (IRE1α)/TNF receptor-associated factor 2 (TRAF2)/TNF-α pathway.46 In addition, sustained ER stress also induces cell death due to failure in UPR signaling to induce the homeostatic adaptation of cells.47

In mammalian cells, ER stress evokes UPR to resolve constraint inside the ER.44 UPRs consist of three highly conserved pathways including PKR-like eukaryotic initiation factor 2α kinase (PERK), IRE1, and activating transcription factor-6 (ATF6). Among them, the IRE1a pathway includes splicing of a gene encoding XBP1.4 Spliced XBP1 (sXBP1) is critical for the functions of the ER such as expansion and secretion, especially in several highly secretory cells including plasma cells and pancreatic and salivary gland epithelial cells.48,49 The function of the unspliced form of XBP1 (uXPB1) is not well known, and uXBP1 is highly unstable.4 Instead, sXPB1 triggers the transcription of genes for the quality control and maintenance of ER functions. IRE1 is an ancestrally conserved pathway of UPR, and also possesses kinase activity to phosphorylate TRAF2 as well as endonuclease activity. 4 Accordingly, intestinal epithelial cell-specific depletion of XBP1 is known to initiate spontaneous small intestinal inflammation in mice.

UPR is known to intersect with several inflammatory pathways including IκB kinase (IKK) and c-Jun N-terminal kinases (JNK),50,51 and is also associated with inflammation in obese and diabetic patients.52 In addition, ER stress has been associated with the development of IBD.4 In humans, several genes associated with ER stress including XBP1, anterior gradient 2 (AGR2), mucin 19 (MUC19), and ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3) have been reported as genetic risk factors for IBD, and increased ER stress has been observed in patients with IBD.5 In several mouse models, ER stress induced by deletion of some ER chaperones such as ATF6 or p58^IPK led to the development of severe intestinal inflammation after dextran sulfate sodium (DSS) administration,53 and the administration of chemical chaperones including 4-phenylbutyrate and tauroursodeoxycholate ameliorated colitis in those mice.53 In addition, conditional knockout of XBP1 in intestinal epithelial cells causes small intestinal enteritis with crypt abscesses reminiscent of human IBD,4 and AGR2 knockout mice develop granulomatous ileocolitis.54 Interestingly, UPR signaling was found to be impaired in colonic epithelial cells of protein kinase RNA-activated (PKR)^-/- mice with a reduced level of phosphorylated eIF2α and diminished ER chaperons, resulting in more severe DSS-induced colitis in these mice.55 In addition, glutamine treatment attenuates ER stress increased in a trinitrobenzene sulfonate (TNBS)-treated colitis model through modulation of UPR signaling, and diminishes the severity of macroscopic damage and apoptotic cell death.56

ER STRESS AND THE DIVERGENT FUNCTIONS OF MDSCs

In tumor-bearing hosts, it has been reported that ER stress is transmitted from tumor cells to myeloid cells.57 In association with increased inflammation by ER stress, ER stress-conditioned medium obtained from tumor cells culture with ER stress inducers resulted in up-regulation of ER stress in myeloid cells. Similarly, infectious ER stress has also been reported in tumor cells, which was known to be mediated by Par-4 secreted by ER stressed cells.58 Hypoxic tumor micro-environments could induce an ER stress condition, as well as increased reactive oxygen species generated in MDSCs induced ER stress. Increased ER stress results in early apoptosis of MDSCs in a TNF-related apoptosis-inducing ligand-receptor (TRAIL-R)-dependent manner, which in turn accelerates the generation of MDSCs in bone marrow. Indeed, MDSCs found in tumor-bearing mice and cancer patients showed significantly higher levels of ER stress compared with healthy controls.59 However, it is not clear whether ER stress increased in IBD condition influences on intestinal MDSCs found in IBD patients as well as on their immuno-suppressive or inflammatory functions.

Although aggravation of inflammation by ER stress seems to be certain in several disease conditions, the mechanism by which ER stress triggers inflammation remains largely unknown. IRE1/TRAF2-mediated JNK activation and the nuclear factor-κB (NF-κB) pathway could explain the inflammatory responses observed in the ER stress condition. ER stress also activates cleavage of ATF6 to activate the expression of acute-phase protein genes in the liver, and mediates acute inflammatory responses.60 Recent studies have also suggested the role of the nucleotide-binding oligomerization domain, leucine rich repeat, and pyrin domain containing 3 (NALP3) inflammasome in chronic inflammatory disease with ER stress.61 Unregulated activation of caspase-1 and subsequent overproduction of IL-1β through inflammasome activation might be associated with the perpetuation of IBD. Indeed, there is an increased level of IL-1β in the intestinal specimens of IBD patients.62 On the contrary, loss of function in NOD2 or inflammasomes could result in dysbiosis by decreased IL-1β.63 Thus, the involvement of several genetic risk factors, including NOD2, ATG16L1, NALP3, and chemokine (C-C motif) receptor 6 in the inflammatory status of MDSCs need to be further elucidated.

CONCLUSIONS

ER stress responses in MDSCs as well as in intestinal epithelial cells might be critical for the homeostatic regulation of gut immunity. In this review, we focused on the roles of MDSCs on intestinal inflammation, especially in animal models of IBD and also in IBD patients. The recent advances in experimental techniques for intestinal tissues, wide availability of germ-free mice, genome-wide analysis of patients' genetic information, and metagenomic analysis of commensals increase the understanding of the development and progress of IBD, and hence provide some clues for the development of therapeutic drugs for the treatment of IBD. In particular, some strategies to regulate ER stress responses in MDSCs as well as in the intestinal epithelium might be novel ways to prevent or treat intestinal inflammation in IBD patients.

NOTES

Financial support: This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2014R1A2A2A01002576).

Conflict of interest: None.

REFERENCES

1. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012;380:1590–1605.PMID: 22914295.Article PubMed
2. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603–606.PMID: 11385577.Article PubMed PDF
3. Henckaerts L, Figueroa C, Vermeire S, Sans M. The role of genetics in inflammatory bowel disease. Curr Drug Targets 2008;9:361–368.PMID: 18473763.Article PubMed
4. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008;134:743–756.PMID: 18775308.Article PubMed PMC
5. Kaser A, Zeissig S, Blumberg RS. Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future? Dig Dis 2010;28:395–405.PMID: 20926863.Article PubMed PMC
6. Adolph TE, Tomczak MF, Niederreiter L, et al. Paneth cells as a site of origin for intestinal inflammation. Nature 2013;503:272–276.PMID: 24089213.Article PubMed PMC PDF
7. Koslowski MJ, Teltschik Z, Beisner J, et al. Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease. PLoS Genet doi: 10.1371/journal.pgen.1002523 Published online 23 Feburary 2012.Article
8. Farin HF, Karthaus WR, Kujala P, et al. Paneth cell extrusion and release of antimicrobial products is directly controlled by immune cell-derived IFN-gamma. J Exp Med 2014;211:1393–1405.PMID: 24980747.Article PubMed PMC
9. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004;53:1658–1664.PMID: 15479689.Article PubMed PMC
10. Koslowski MJ, Kubler I, Chamaillard M, et al. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS One doi: 10.1371/journal.pone.0004496 Published online 16 Feburary 2009.Article
11. Fournier BM, Parkos CA. The role of neutrophils during intestinal inflammation. Mucosal Immunol 2012;5:354–366.PMID: 22491176.Article PubMed PDF
12. Varol C, Vallon-Eberhard A, Elinav E, et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009;31:502–512.PMID: 19733097.Article PubMed
13. Ostanin DV, Bhattacharya D. Myeloid-derived suppressor cells in the inflammatory bowel diseases. Inflamm Bowel Dis 2013;19:2468–2477.PMID: 23811636.Article PubMed
14. Gabrilovich DI, Bronte V, Chen SH, et al. The terminology issue for myeloid-derived suppressor cells. Cancer Res 2007;67:425author reply 426. PMID: 17210725.Article PubMed PMC
15. Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer 2013;13:739–752.PMID: 24060865.Article PubMed PMC PDF
16. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162–174.PMID: 19197294.Article PubMed PMC
17. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008;181:5791–5802.PMID: 18832739.Article PubMed PMC
18. Kim YS, Kim YJ, Lee JM, et al. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs. J Immunol 2012;188:4226–4234.PMID: 22474024.Article PubMed
19. Hong EH, Chang SY, Lee BR, et al. Intratumoral injection of attenuated Salmonella vaccine can induce tumor microenvironmental shift from immune suppressive to immunogenic. Vaccine 2013;31:1377–1384.PMID: 23318147.Article PubMed
20. Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010;40:2969–2975.PMID: 21061430.Article PubMed PMC
21. Ko JS, Zea AH, Rini BI, et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res 2009;15:2148–2157.PMID: 19276286.Article PubMed
22. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012;12:253–268.PMID: 22437938.Article PubMed PMC PDF
23. Serafini P, Mgebroff S, Noonan K, Borrello I. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 2008;68:5439–5449.PMID: 18593947.Article PubMed PMC
24. Hoechst B, Voigtlaender T, Ormandy L, et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009;50:799–807.PMID: 19551844.Article PubMed PMC
25. Hu CE, Gan J, Zhang RD, Cheng YR, Huang GJ. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function. Scand J Gastroenterol 2011;46:156–164.PMID: 20822377.Article PubMed
26. Chang SY, Kim YJ, Ko HJ. Potential therapeutic anti-tumor effect of a Salmonella-based vaccine. Hum Vaccin Immunother 2013;9:1654–1660.PMID: 23733040.Article PubMed PMC
27. Cuenca AG, Delano MJ, Kelly-Scumpia KM, et al. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med 2011;17:281–292.PMID: 21085745.Article PubMed
28. Tomihara K, Guo M, Shin T, et al. Antigen-specific immunity and cross-priming by epithelial ovarian carcinoma-induced CD11b⁺Gr-1⁺ cells. J Immunol 2010;184:6151–6160.PMID: 20427766.Article PubMed
29. Ko HJ, Lee JM, Kim YJ, Kim YS, Lee KA, Kang CY. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine. J Immunol 2009;182:1818–1828.PMID: 19201833.Article PubMed
30. Lee JM, Seo JH, Kim YJ, Kim YS, Ko HJ, Kang CY. The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treatment. Int J Cancer 2012;131:741–751.PMID: 21898392.Article PubMed
31. Fakhoury M, Negrulj R, Mooranian A, Al-Salami H. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res 2014;7:113–120.PMID: 25075198.Article PubMed PMC
32. Haile LA, von Wasielewski R, Gamrekelashvili J, et al. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 2008;135:871–881.PMID: 18674538.Article PubMed
33. Ostanin DV, Kurmaeva E, Furr K, et al. Acquisition of antigen-presenting functions by neutrophils isolated from mice with chronic colitis. J Immunol 2012;188:1491–1502.PMID: 22219329.Article PubMed PMC
34. Rivollier A, He J, Kole A, Valatas V, Kelsall BL. Inflammation switches the differentiation program of Ly6C^hi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 2012;209:139–155.PMID: 22231304.Article PubMed PMC
35. Leppkes M, Becker C, Ivanov II, et al. RORγ-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009;136:257–267.PMID: 18992745.Article PubMed
36. O'Connor W Jr, Kamanaka M, Booth CJ, et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009;10:603–609.PMID: 19448631.Article PubMed PMC PDF
37. Yi H, Guo C, Yu X, Zuo D, Wang XY. Mouse CD11b⁺Gr-1⁺ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J Immunol 2012;189:4295–4304.PMID: 23034169.Article PubMed PMC
38. Kurmaeva E, Bhattacharya D, Goodman W, et al. Immuno-suppressive monocytes: possible homeostatic mechanism to restrain chronic intestinal inflammation. J Leukoc Biol 2014;96:377–389.PMID: 24696357.Article PubMed PMC
39. Guan Q, Moreno S, Qing G, et al. The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis. J Leukoc Biol 2013;94:803–811.PMID: 23901119.Article PubMed
40. McGuckin MA, Eri RD, Das I, Lourie R, Florin TH. ER stress and the unfolded protein response in intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2010;298:G820–G832.PMID: 20338921.Article PubMed
41. Mandl J, Meszaros T, Banhegyi G, Csala M. Minireview: endoplasmic reticulum stress: control in protein, lipid, and signal homeostasis. Mol Endocrinol 2013;27:384–393.PMID: 23349523.Article PubMed PMC PDF
42. Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 1999;13:1211–1233.PMID: 10346810.Article PubMed
43. Jheng JR, Ho JY, Horng JT. ER stress, autophagy, and RNA viruses. Front Microbiol 2014;5:388PMID: 25140166.Article PubMed PMC
44. Todd DJ, Lee AH, Glimcher LH. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 2008;8:663–674.PMID: 18670423.Article PubMed PDF
45. Baird TD, Wek RC. Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism. Adv Nutr 2012;3:307–321.PMID: 22585904.Article PubMed PMC PDF
46. Garg AD, Kaczmarek A, Krysko O, Vandenabeele P, Krysko DV, Agostinis P. ER stress-induced inflammation: does it aid or impede disease progression? Trends Mol Med 2012;18:589–598.PMID: 22883813.Article PubMed
47. Kim I, Xu W, Reed JC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 2008;7:1013–1030.PMID: 19043451.Article PubMed PDF
48. Todd DJ, McHeyzer-Williams LJ, Kowal C, et al. XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development. J Exp Med 2009;206:2151–2159.PMID: 19752183.Article PubMed PMC
49. Lee AH, Chu GC, Iwakoshi NN, Glimcher LH. XBP-1 is required for biogenesis of cellular secretory machinery of exocrine glands. EMBO J 2005;24:4368–4380.PMID: 16362047.Article PubMed PMC
50. Deng J, Lu PD, Zhang Y, et al. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol 2004;24:10161–10168.PMID: 15542827.Article PubMed PMC
51. Hu P, Han Z, Couvillon AD, Kaufman RJ, Exton JH. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1α-mediated NF-κB activation and down-regulation of TRAF2 expression. Mol Cell Biol 2006;26:3071–3084.PMID: 16581782.Article PubMed PMC
52. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010;140:900–917.PMID: 20303879.Article PubMed PMC
53. Cao SS, Zimmermann EM, Chuang BM, et al. The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice. Gastroenterology 2013;144:989–1000.PMID: 23336977.Article PubMed PMC
54. Park SW, Zhen G, Verhaeghe C, et al. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc Natl Acad Sci U S A 2009;106:6950–6955.PMID: 19359471.Article PubMed PMC
55. Cao SS, Song B, Kaufman RJ. PKR protects colonic epithelium against colitis through the unfolded protein response and prosurvival signaling. Inflamm Bowel Dis 2012;18:1735–1742.PMID: 22275310.Article PubMed PMC
56. Crespo I, San-Miguel B, Prause C, et al. Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis. PLoS One doi: 10.1371/journal.pone.0050407 Published online 28 November 2012.Article
57. Mahadevan NR, Rodvold J, Sepulveda H, Rossi S, Drew AF, Zanetti M. Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells. Proc Natl Acad Sci U S A 2011;108:6561–6566.PMID: 21464300.Article PubMed PMC
58. Burikhanov R, Zhao Y, Goswami A, Qiu S, Schwarze SR, Rangnekar VM. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell 2009;138:377–388.PMID: 19632185.Article PubMed PMC
59. Condamine T, Kumar V, Ramachandran IR, et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J Clin Invest 2014;124:2626–2639.PMID: 24789911.Article PubMed PMC
60. Zhang K, Shen X, Wu J, et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 2006;124:587–599.PMID: 16469704.Article PubMed
61. Menu P, Mayor A, Zhou R, et al. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway. Cell Death Dis 2012;3:e261PMID: 22278288.Article PubMed PMC PDF
62. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995;154:2434–2440.PMID: 7868909.Article PubMed PDF
63. Villani AC, Lemire M, Fortin G, et al. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet 2009;41:71–76.PMID: 19098911.Article PubMed PDF
64. Zhang R, Ito S, Nishio N, Cheng Z, Suzuki H, Isobe K. Up-regulation of Gr1+CD11b+ population in spleen of dextran sulfate sodium administered mice works to repair colitis. Inflamm Allergy Drug Targets 2011;10:39–46.PMID: 21184649.Article PubMed
65. Singh UP, Singh NP, Singh B, et al. Role of resveratrol-induced CD11b⁺Gr-1⁺ myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3⁺ T cells and amelioration of chronic colitis in IL-10^-/- mice. Brain Behav Immun 2012;26:72–82.PMID: 21807089.Article PubMed

Table 1

Pros and Cons of Myeloid-Derived Suppressor Cells (MDSCs) in IBS

TNBS, trinitrobenzene sulfonic acid; IFN-γ, interferon γ; IL-17, interleukin 17; TNF-α, tumor necrosis factor α; DSS, dextran sulfate sodium; GM-CSF, granulocyte-macrophage colony-stimulating factor; DCs, dendritic cells; RAG-1, recombination activation gene-1; iNOS, inducible nitric oxide synthase.

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Sulforaphane Attenuates AOM/DSS-Induced Colorectal Tumorigenesis in Mice via Inhibition of Intestinal Inflammation
Fang Shao, Jie Pan, Yewen Xie, Jun Ding, Xiao Sun, Lei Xia, Dawei Zhu, Shizhong Wang, Chunjian Qi
Nutrition and Cancer.2024; 76(1): 137. CrossRef
Local administration of myeloid-derived suppressor cells prevents progression of immune-mediated dry eye disease
Pier Luigi Surico, Seokjoo Lee, Rohan Bir Singh, Amirreza Naderi, Shilpy Bhullar, Tomas Blanco, Yihe Chen, Reza Dana
Experimental Eye Research.2024; 242: 109871. CrossRef
Dexamethasone promotes renal fibrosis by upregulating ILT4 expression in myeloid‐derived suppressor cells
Xiaowen Gu, Lianmei Zhang, Min Sun, Ying Zhou, Jinling Ji, YunFang Xu, Jianguo You, Zhikui Deng
Journal of Cellular and Molecular Medicine.2024;[Epub] CrossRef
Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease
Xiaoli Lou, Deyong Gao, Liyuan Yang, Yue Wang, Yanqiang Hou
Journal of Translational Medicine.2023;[Epub] CrossRef
Mesenchymal Stem Cells and Myeloid-Derived Suppressor Cells Interplay in Adjuvant-Induced Arthritis Rat Model
Faten A.M. Abo-Aziza, Basma M. Wasfy, Sanaa M.R. Wahba, Sahar S. Abd-Elhalem
International Immunopharmacology.2023; 120: 110300. CrossRef
TMPRSS11D/ALR-mediated ER stress regulates the function of myeloid-derived suppressor cells in the cervical cancer microenvironment
Sifang Feng, Juan Zhao, Ting Yang, Long Li
International Immunopharmacology.2023; 124: 110869. CrossRef
Glycolysis inhibition ameliorates brain injury after ischemic stroke by promoting the function of myeloid-derived suppressor cells
Jingwei Yan, Anqi Li, Xianglin Chen, Kaixiang Cao, Mingchuan Song, Shuai Guo, Zou Li, Shuqi Huang, Ziling Li, Danghan Xu, Yong Wang, Xiaoyan Dai, Du Feng, Yuqing Huo, Jun He, Yiming Xu
Pharmacological Research.2022; 179: 106208. CrossRef
Myeloid-derived suppressor cells in transplantation tolerance induction
Peng Cao, Zejia Sun, Chang Feng, Jiandong Zhang, Feilong Zhang, Wei Wang, Yong Zhao
International Immunopharmacology.2020; 83: 106421. CrossRef
Myeloid-Derived Suppressor Cell-Derived Arginase-1 Oppositely Modulates IL-17A and IL-17F Through the ESR/STAT3 Pathway During Colitis in Mice
Zhanchuan Ma, Yu Zhen, Cong Hu, Huanfa Yi
Frontiers in Immunology.2020;[Epub] CrossRef
Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14
Simon H. Murch
Medical Hypotheses.2020; 144: 110168. CrossRef
Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting
Vijay Kumar
Inflammation.2019; 42(3): 765. CrossRef
Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B
William van der Touw, Kyeongah Kang, Yi Luan, Ge Ma, Sunny Mai, Lihui Qin, Guanglin Bian, Ruihua Zhang, Sathish Kumar Mungamuri, Hong-Ming Hu, Cheng Cheng Zhang, Stuart A Aaronson, Marc Feldmann, Wen-Chin Yang, Shu-Hsia Chen, Ping-Ying Pan
The Journal of Immunology.2018; 201(6): 1727. CrossRef
The Expansion of Myeloid-Derived Suppressor Cells Is Associated with Joint Inflammation in Rheumatic Patients with Arthritis
Junqing Zhu, Shixian Chen, Lisheng Wu, Ran Wang, Songyuan Zheng, Di Zhao, Xiangyang Wang, Juan Li
BioMed Research International.2018; 2018: 1. CrossRef
Lymph node macrophages: drug-related reaction or infectious-lesion?
Adriana Handra-Luca
Intestinal Research.2018; 16(4): 646. CrossRef
TGF-Β as a Marker of Ulcerative Colitis and Disease Severity
Marina Jovanovic, Natasa Zdravkovic, Ivan Jovanovic, Gordana Radosavljevic, Nevena Gajovic, Nebojsa Zdravkovic, Veljko Maric, Nebojsa Arsenijevic
Serbian Journal of Experimental and Clinical Research.2018; 19(3): 229. CrossRef
Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis
Min Li, Dongwei Zhu, Tingting Wang, Xueli Xia, Jie Tian, Shengjun Wang
Frontiers in Immunology.2018;[Epub] CrossRef
Chlorogenic acid suppresses lipopolysaccharide-induced nitric oxide and interleukin-1β expression by inhibiting JAK2/STAT3 activation in RAW264.7 cells
Sang-Hun Kim, Sun-Young Park, Young-Lan Park, Dae-Seong Myung, Jong-Sun Rew, Young-Eun Joo
Molecular Medicine Reports.2017; 16(6): 9224. CrossRef
The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis
Yungang Wang, Jie Tian, Shengjun Wang
Seminars in Arthritis and Rheumatism.2016; 45(4): 490. CrossRef
Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease
Yaron Ilan
Clinical & Translational Immunology.2016;[Epub] CrossRef
The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation
Chao Zhang, Shuo Wang, Cheng Yang, Ruiming Rong
Journal of Immunology Research.2016; 2016: 1. CrossRef
Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice
Yungang Wang, Jie Tian, Xinyi Tang, Ke Rui, Xinyu Tian, Jie Ma, Bin Ma, Huaxi Xu, Liwei Lu, Shengjun Wang
Oncotarget.2016; 7(13): 15356. CrossRef

PubReader

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format: